Inventor
Lars Björck
Inventor
Lund, SE
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07KPeptides18%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests11%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
Y02ATechnologies for adaptation to climate change7%
A61BDiagnosis3%
C12NMicroorganisms or enzymes3%
A61MDevices for introducing media into, or onto, the body1%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
PatentTitleYear
10,126,312Diagnostic method for urinary tract infection20189,784,741'Diagnostic method'20179,759,720'Diagnostic method for bacterial meningitis'20178,889,128'Use of the endoglycosidase endos for treating immunoglobulin G mediated diseases'20148,518,648'Diagnostic method'20138,133,483'Method of treating or preventing a disease or condition mediated by pathogenic IgG antibodies'20127,666,582'IdeS, an IgG-degrading enzyme of Streptococcus pyogenes'20107,588,762'Streptoccal inhibitor of complement-mediated lysis, protein SIC'20097,361,750'Streptoccal inhibitor of complement-mediated lysis, protein SIC'20087,335,355'Antimicrobial agent'20087,176,178'Nuclear targeting by means of bacterial proteins'20076,843,999'Streptococcal ABC transporter protein'20056,833,355'Use of protein H as cytostatic agent'20046,822,075'Protein L and hybrid proteins thereof'20046,576,741'Streptoccal inhibitor of complement-mediated lysis, protein SIC'20036,242,210'Treatment of bacterial infections'20016,221,845'Use of kinin antagonists for preparing a pharmaceutical composition for treating bacterial infections'20015,965,390'Protein L and hybrid proteins thereof'19995,278,297'Gene encoding a novel protein H capable of binding to IgG'19945,180,810'Protein H capable of binding to IgG'19935,108,894'Protein G and/or fragments thereof'19924,948,874'Purified protein G from streptococcal bacteria'19904,876,194'Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain'1989Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1989–1994Patents assigned to HIGHTECH RECEPTOR AB (3)· patent assignee history
1989–1999Based in Sodra Sandby, SE· patent location history
1999–2005Patents assigned to ACTINOVA LTD (4)· patent assignee history
2001–2018Based in Lund, SE· patent location history
2003–2018Patents assigned to HANSA MEDICAL AB (10)· patent assignee history
2004Based in Södra Sandby, SE· patent location history
2012–2013Patents assigned to BJOERCK LARS (2)· patent assignee history
2014–2017Patents assigned to BJÖRCK LARS (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HANSA MEDICAL AB | 10 | 2003–2018 |
| ACTINOVA LTD | 4 | 1999–2005 |
| HIGHTECH RECEPTOR AB | 3 | 1989–1994 |
| BJOERCK LARS | 2 | 2012–2013 |
| BJÖRCK LARSself | 2 | 2014–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Lund, SE | 16 | 2001–2018 |
| Sodra Sandby, SE | 6 | 1989–1999 |
| Södra Sandby, SE | 1 | 2004 |